Zelira Therapeutics Ltd ZLDAF
Trading Information
- Previous Close Price
- $0.26
- Day Range
- $0.26–0.26
- 52-Week Range
- $0.20–0.42
- Bid/Ask
- $0.01 / $0.40
- Shares Outstanding
- 13.15M
- Market Cap
- $3.09M
- Volume/Avg
- 282 / 1,173
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 7,049.88
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Zelira Therapeutics Ltd is a biotechnology company focused on developing a range of cannabinoid-based formulations for the treatment of various medical conditions in Australia. The company is involved in a human clinical trial program focused on insomnia, autism, and eczema, and a pre-clinical research program to examine the effect of cannabinoids in breast, brain, and pancreatic cancer. The company is organised into two operating segments based on geographic location of operations: Australia and United States of America.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 8
- Website
- https://www.zeliratx.com
Valuation
|
Metric
|
ZLDAF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 7,049.88 |
Price/Cash Flow | — |
Price/Earnings
ZLDAF
Financial Strength
|
Metric
|
ZLDAF
|
|---|---|
Quick Ratio | 0.01 |
Current Ratio | 0.11 |
Interest Coverage | — |
Quick Ratio
ZLDAF
Profitability
|
Metric
|
ZLDAF
|
|---|---|
Return on Assets (Normalized) | — |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
ZLDAF
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|LV?>>m# | LOCK|%^Mj | $129B | |||
| Moderna Inc
MRNA
| LOCK|w$L#<n | LOCK|Czv | $85B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|&y!pS>f | LOCK|f$HF | $79B | |||
| argenx SE ADR
ARGX
| LOCK|$<CgNZB | LOCK|$r> | $52B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|NXZm!$ | LOCK|?Y | $41B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|vT$C<$ | LOCK|<G#pB | $30B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|^K!$#<& | LOCK|!r@< | $26B | |||
| BioNTech SE ADR
BNTX
| LOCK|q$p&Z! | LOCK|j#Z | $24B | |||
| Incyte Corp
INCY
| LOCK|wnBD<fs | LOCK|vp | $23B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|B@gKMH^ | LOCK|nSc | $14B |
United States